Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11918584 Combination therapy including a KRAS

Patent 11918584 was granted and assigned to Amgen on March, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 11 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12083121 Substituted piperazines as KRAS G12C inhibitors
0
Edits on 12 Mar, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 12 Mar, 2024
Edits made to:
Infobox (+53 properties)
‌

 US Patent 11918584 Combination therapy including a KRAS

Infobox
Is a
Patent
Patent
0
Patent Applicant
Amgen
Amgen
0
Current Assignee
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119185840
Patent Inventor Names
Anne Y. Saiki0
James Russell Lipford0
Jude Robert Canon0
Karen Louise Rex0
Date of Patent
March 5, 2024
0
Patent Application Number
178705730
Date Filed
July 21, 2022
0
Patent Citations
‌
US Patent 11096939 KRAS G12C inhibitors and methods of using the same
0
‌
US Patent 11090304 KRAS G12C inhibitors and methods of using the same
0
‌
US Patent 7354944 Thiadiazole compounds and methods of use
0
‌
US Patent 7361760 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
0
‌
US Patent 7514566 Thiazole compounds and methods of use
0
‌
US Patent 7618632 Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies
0
‌
US Patent 7700636 Thiadiazole compounds and methods of use
0
‌
US Patent 7812135 GITR-binding antibodies
0
‌
US Patent 7897619 Heterocyclic modulators of PKB
0
‌
US Patent 7919504 Thiadiazole modulators of PKB
0
‌
US Patent 7919514 Thiadiazole compounds and methods of use
0
‌
US Patent 8388967 Methods for inducing or enhancing an immune response by administering agonistic GITR-binding antibodies
0
‌
US Patent 8586023 Cell capable of expressing exogenous GITR ligand
0
‌
US Patent 8591886 Combination therapies employing GITR binding molecules
0
‌
US Patent 10519146 KRAS G12C inhibitors and methods of using the same
0
‌
US Patent 10532042 KRAS G12C inhibitors and methods of using the same
0
‌
US Patent 11236091 Solid state forms
0
‌
US Patent 10640504 Inhibitors of KRAS G12C and methods of using the same
0
‌
US Patent 10988485 KRAS G12C inhibitors and methods of using the same
0
‌
US Patent 11045484 KRAS G12C inhibitors and methods of using the same
0
‌
US Patent 11053226 KRAS G12C inhibitors and methods of using the same
0
‌
US Patent 11285135 KRAS G12C inhibitors and methods of using the same
0
‌
US Patent 11285156 Substituted piperazines as KRAS G12C inhibitors
0
‌
US Patent 11299491 Synthesis of key intermediate of KRAS G12C inhibitor compound
0
‌
US Patent 11306087 Inhibitors of KRAS G12C and methods of using the same
0
‌
US Patent 11426404 Dosing of
0
‌
US Patent 11439645 Combination therapy including a KRAS
0
‌
US Patent 7025962 Mammalian cell surface antigens; related reagents
0
Patent Primary Examiner
‌
Sun Jae Yoo
0
CPC Code
‌
C07K 16/2818
0
‌
A61K 2300/00
0
‌
A61K 45/06
0
‌
A61K 39/39566
0
‌
A61K 39/39558
0
‌
A61K 39/3955
0
‌
A61P 35/00
0
‌
A61K 31/555
0
‌
A61K 31/519
0
‌
A61K 31/506
0
‌
A61K 31/497
0
‌
A61K 2039/505
0

Find more entities like US Patent 11918584 Combination therapy including a KRAS

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo